CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Net revenue	$ 820,314	$ 805,858	$ 2,398,568	$ 2,404,330
Revenue, Product and Service [Extensible Enumeration]			Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	658,372	643,795	$ 1,961,530	$ 1,915,447
Cost, Product and Service [Extensible Enumeration]			Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	90,111	87,313	$ 274,401	$ 275,717
Depreciation and amortization, excluding patient equipment depreciation	10,101	11,263	30,710	34,023
Goodwill impairment (note 7)	0	0	0	13,078
Total costs and expenses	758,584	742,371	2,266,641	2,238,265
Gain on sale of businesses	0	0	(32,225)	0
Operating income	61,730	63,487	164,152	166,065
Interest expense, net	25,380	31,429	81,312	96,939
Loss on extinguishment of debt	0	2,273	0	2,273
Change in fair value of warrant liability (note 12)	0	(2,243)	0	(1,800)
Other loss	0	0	0	3,345
Income before income taxes	36,350	32,028	82,840	65,308
Income tax expense (benefit)	10,600	8,073	47,341	21,931
Net income	25,750	23,955	35,499	43,377
Income attributable to noncontrolling interest	1,241	1,096	3,523	3,217
Net income attributable to AdaptHealth Corp.	$ 24,509	$ 22,859	$ 31,976	$ 40,160
Weighted average common shares outstanding - basic (in shares)	135,345	134,303	135,048	133,481
Weighted average common shares outstanding - diluted (in shares)	137,211	136,530	137,102	135,441
Basic net income per share (in dollars per share)	$ 0.17	$ 0.16	$ 0.22	$ 0.28
Diluted net income per share (in dollars per share)	$ 0.16	$ 0.15	$ 0.21	$ 0.27